Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
05/2007
05/30/2007CN1318390C Use of trans-pellitorin in the form of an aromatic substance
05/29/2007US7223888 Mu opioid receptor ligands: methods of use and synthesis
05/29/2007US7223887 Multivalent cationic lipids and methods of using same in the production of lipid particles
05/29/2007US7223882 Reacting 2-amido-alkoxycarbonyl-benzaldehyde compound with alkoxycarbonyl-phosphonate compound, in the presence of lithium hydroxide in an organic solvent, adding lithium hydroxide adding an acid to the solution to obtain triterpene derivative
05/29/2007US7223879 Reactibng transition metal with boron compound and sulfonate compound
05/29/2007US7223859 carbamylation of (R)-4-ethyl-1-[4-(trifluoromethyl)phenyl]-2-azetidinone, with carbamic acid, methyl or benzyl esters, to form chemical intermediates for cholesteryl ester transfer protein inhibitors
05/29/2007US7223805 Ultraviolet light absorbing 2-methoxyphenol derivative
05/29/2007US7223774 Benzamide 2-hydroxy-3-diaminoalkanes
05/24/2007WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases
05/24/2007WO2007058156A1 Tetracarboxylic acid compound, polyimide thereof, and production method thereof
05/24/2007WO2006119758B1 Dihydroxyphenylalanine derivatives
05/24/2007WO2006071960A3 Compositions and methods of treating cell proliferation disorders
05/24/2007US20070117803 Cyclohexyl-1,4-diamine compounds
05/24/2007US20070117740 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
05/23/2007EP1786799A1 Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
05/23/2007EP1786786A1 Adamantyl derivates as p2x7 receptor antagonists
05/23/2007EP1786381A1 Anti-bacterial compounds
05/23/2007EP1654213B1 Matrix metalloproteinase inhibitors
05/23/2007EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
05/23/2007CN1968686A Guanylhydrazone salts, compositions, processes of making and methods of using
05/23/2007CN1966485A Method for synthesizing shikimic acid derivative
05/23/2007CN1317259C Process for recovering dimethyl formyl amide from waste water
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220871 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification
05/22/2007US7220783 Para-terphenyl compounds
05/22/2007CA2276694C New fatty acid derivatives
05/18/2007WO2007055414A1 Polymer having sulfonic acid group or sulfonic acid ester group and amide group, and toner for developing electrostatic latent image having the polymer
05/18/2007WO2007055180A1 Method for producing optically active trans-2-aminocyclohexanol and derivative thereof
05/18/2007WO2007054254A1 Organic compounds
05/18/2007WO2007036585A3 Pesticide formulations which risk crystallisation and process for producing the same
05/18/2007WO2007000340A8 Bicyclic derivatives as p38 kinase inhibitors
05/18/2007CA2626705A1 Organic compounds
05/17/2007US20070112232 Reacting halogen and hydroxy substituted aromatic compounds with an alkali metal or in a nitrogen base and an alcohol; hydroxyl group prevents dehalogenation; selectively retaining a halogen group on an aromatic ring
05/17/2007US20070112201 Intermediates to a copper bisoxazoline catalyst for asymmetric synthesis of agrochemical or pharmaceutical intermediates such as insecticides; reacting a cycloalkylidenemalonic diester with an aminoalcohol to form amide intermediate; cyclization to ligand e.g. 1,1-bis[2-[tert-butyloxazoline]]cyclopropane
05/17/2007US20070112007 Cyclohexyl-1, 4-diamine compounds
05/17/2007US20070111927 Peptoid compounds
05/17/2007US20070111923 Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition
05/16/2007EP1784383A1 Method for the production of biphenylamines
05/16/2007CN1965002A Polymer having sulfonic acid group or sulfonic ester group and amide group, and method of producing the same
05/16/2007CN1964955A Small molecules for treatment of hypercholesterolemia and related diseases
05/16/2007CN1964941A 有机活化剂 Organic activator
05/16/2007CN1964940A Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
05/16/2007CN1962615A Diamine compound for resisting hepatitis B virus and its preparation method and its application
05/16/2007CN1962614A Felbinac acetaminopher ester and its preparation method
05/16/2007CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
05/16/2007CN1315794C New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine
05/16/2007CN1315785C Beta-hydroxy alkylamide, preparation and use thereof
05/16/2007CN1315784C Industrial production of natural capsaicin crystal by molecular distilling and washing method
05/16/2007CN1315780C Process for producing n-formyl-1-aryl aminomethane
05/15/2007US7217845 Bifunctional polyethylene glycol derivatives
05/15/2007US7217838 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
05/15/2007US7217738 β2-adrenergic receptor agonists
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/15/2007CA2236293C Intermediates for the hemisynthesis of taxanes and processes for their preparation
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105913 Alkynyl aryl carboxamides
05/10/2007US20070105899 Benzene compounds
05/10/2007US20070105850 2,4-diChloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents
05/10/2007US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring
05/10/2007DE102005052847A1 Preparation of N-(1-(hetero)aryl-alk-1-enyl)-acetamide, useful to prepare ketones, comprises reaction of N-(alk-1-enyl)-acetamide with (hetero)aryl chloride in the presence palladium-catalyst, water/ionic liquid and dimethylformamide
05/09/2007EP1781274A1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions
05/09/2007CN1958563A Method for producing derivative of fatty acid of carbochain
05/09/2007CN1314660C Cinnamide compound synthesizing process
05/09/2007CN1314655C Method for preparing 4-nitroso-substituted aromatic amine
05/08/2007US7214827 To make ketoaniline derivatives, using as a catalyst a tri(perfluoroalkane sulfonate) salt of specified elements such as Gallium; bonding of acyl group to a benzene ring
05/08/2007US7214814 Additives for inhibiting gas hydrate formation
05/08/2007US7214803 Amidation of an alpha-pyrrolidinonylalkanoate by reaction with ammonium hydroxide
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/03/2007WO2007049729A2 Amide compounds and their use
05/03/2007WO2007002248A3 Modified malonate derivatives
05/03/2007US20070100031 Ultraviolet light absorbers
05/03/2007DE102005051325A1 Alkoxyalkyl spirocyclische Tetram- und Tetronsäuren Alkoxyalkyl spirocyclic tetramic and tetronic acids
05/03/2007CA2625541A1 Ppar modulating biaromatic compounds
05/02/2007EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778638A1 Diaryl ether beta2 adrenergic receptor agonists
05/02/2007EP1778627A1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives
05/02/2007EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators
05/02/2007EP1778623A2 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
05/02/2007EP1778622A1 Para-alkyl-substituted n-(4-hydroxy-3-methoxy-benzyl) cinnamamides and the use thereof for producing drugs
05/02/2007EP1778614A2 Invertible amphiphilic polymers
05/02/2007EP1778214A2 Novel biphenyl compounds and their use
05/02/2007EP1778210A2 Lipid-amino acid conjugates and methods of use
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/02/2007CN1956970A Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof
05/02/2007CN1956951A Method for producing diphenyl azetidinone derivatives
05/02/2007CN1956946A Modulators of cannabinoid receptors
05/02/2007CN1313439C Compounds and compositions for delivering active agents
05/02/2007CN1313438C Preparation method of snail killing agent crude medicine niclosamide
05/02/2007CN1313058C Container assembly for fertilization and culture and embryo transfer
05/02/2007CN1313036C Application of bamboo extractive in heat processing food as acrylamide suppressor
05/01/2007US7211686 Process for making optically active α-amino ketones and selected novel optically active α-amino ketones
05/01/2007US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia
05/01/2007CA2271004C Process for the preparation of optically pure isomers of formoterol
05/01/2007CA2263715C Chiral ferrocenyls
05/01/2007CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 289